Literature DB >> 18539702

Ligand-receptor interactions at the parathyroid hormone receptors: subtype binding selectivity is mediated via an interaction between residue 23 on the ligand and residue 41 on the receptor.

Rosalind Mann1, Mark J Wigglesworth, Dan Donnelly.   

Abstract

Parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP) bind and activate the PTH/PTHrP receptor (PTH-1R). However, while the related receptor PTH-2R responds potently to PTH, it is not activated by PTHrP. Two hormone sites are known to be responsible for these different potencies. First, the absence of efficacy for PTHrP at PTH-2R is due to the presence of His-5 in PTHrP (Ile-5 in PTH), which interacts with the receptor's juxtamembrane domain. Second, PTHrP has lower affinity than PTH for PTH-2R because of the presence of Phe-23 (Trp-23 in PTH), which interacts with the receptor's N-terminal extracellular domain. We used these different receptor subtype properties to demonstrate that residue 41 in PTH-1R, when either the native Leu or substituted by Ile or Met, can accommodate either Phe or Trp at position 23 of the ligand. However, when Leu-41 is substituted by a smaller side chain, either Ala or Val (its equivalent residue in PTH-2R), the receptor becomes highly selective for those peptide ligands with Trp-23. Hence, despite the conservative nature of the substitutions found in the native ligands (Phe for Trp) and receptors (Leu for Val), they nevertheless enable a significant degree of selectivity to be achieved. Analysis of this functionally important ligand-receptor contact, within the context of the recent X-ray structure of the peptide-bound PTH-1R N domain, reveals the nature of the selectivity filter and how it is by-passed in PTH-1R.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18539702     DOI: 10.1124/mol.108.048017

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  7 in total

1.  The major determinant of exendin-4/glucagon-like peptide 1 differential affinity at the rat glucagon-like peptide 1 receptor N-terminal domain is a hydrogen bond from SER-32 of exendin-4.

Authors:  R J Mann; N E Nasr; J K Sinfield; E Paci; D Donnelly
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

2.  Structure of the glucagon receptor in complex with a glucagon analogue.

Authors:  Haonan Zhang; Anna Qiao; Linlin Yang; Ned Van Eps; Klaus S Frederiksen; Dehua Yang; Antao Dai; Xiaoqing Cai; Hui Zhang; Cuiying Yi; Can Cao; Lingli He; Huaiyu Yang; Jesper Lau; Oliver P Ernst; Michael A Hanson; Raymond C Stevens; Ming-Wei Wang; Steffen Reedtz-Runge; Hualiang Jiang; Qiang Zhao; Beili Wu
Journal:  Nature       Date:  2018-01-03       Impact factor: 49.962

Review 3.  International Union of Basic and Clinical Pharmacology. XCIII. The parathyroid hormone receptors--family B G protein-coupled receptors.

Authors:  Thomas J Gardella; Jean-Pierre Vilardaga
Journal:  Pharmacol Rev       Date:  2015       Impact factor: 25.468

4.  Structural basis for parathyroid hormone-related protein binding to the parathyroid hormone receptor and design of conformation-selective peptides.

Authors:  Augen A Pioszak; Naomi R Parker; Thomas J Gardella; H Eric Xu
Journal:  J Biol Chem       Date:  2009-08-12       Impact factor: 5.157

5.  High affinity binding of the peptide agonist TIP-39 to the parathyroid hormone 2 (PTH2) receptor requires the hydroxyl group of Tyr-318 on transmembrane helix 5.

Authors:  Richard E Weaver; Juan C Mobarec; Mark J Wigglesworth; Christopher A Reynolds; Dan Donnelly
Journal:  Biochem Pharmacol       Date:  2016-12-22       Impact factor: 5.858

6.  Small Molecule Inhibited Parathyroid Hormone Mediated cAMP Response by N-Terminal Peptide Binding.

Authors:  Amit Kumar; Monika Baumann; Jochen Balbach
Journal:  Sci Rep       Date:  2016-03-02       Impact factor: 4.379

7.  Structure of the full-length glucagon class B G-protein-coupled receptor.

Authors:  Haonan Zhang; Anna Qiao; Dehua Yang; Linlin Yang; Antao Dai; Chris de Graaf; Steffen Reedtz-Runge; Venkatasubramanian Dharmarajan; Hui Zhang; Gye Won Han; Thomas D Grant; Raymond G Sierra; Uwe Weierstall; Garrett Nelson; Wei Liu; Yanhong Wu; Limin Ma; Xiaoqing Cai; Guangyao Lin; Xiaoai Wu; Zhi Geng; Yuhui Dong; Gaojie Song; Patrick R Griffin; Jesper Lau; Vadim Cherezov; Huaiyu Yang; Michael A Hanson; Raymond C Stevens; Qiang Zhao; Hualiang Jiang; Ming-Wei Wang; Beili Wu
Journal:  Nature       Date:  2017-05-17       Impact factor: 49.962

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.